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Purpose: Osteoarthritis is more prevalent in women than men. Joint
replacement is an effective treatment option for end-stage knee OA and its
utilization is increasing rapidly. There are, however, limited data on gender
differences in surgical outcomes after total joint arthroplasty. We sought to
examine gender differences in overall mortality, major complications,
revision rates and re-admission rates after primary total knee
arthroplasty..
Methods: The sample consisted of all primary knee total joint arthro-
plasties performed in the State of Pennsylvania during the ﬁscal year
2002. Primary knee arthroplasty was identiﬁed using the International
Classiﬁcation of Diseases, Ninth revision, Clinical Modiﬁcation (ICD-9-
CM) code 81.54 in the Pennsylvania Health Care Cost Containment
Council (PHC4) Database. We excluded patients with revision knee
arthroplasty or with hip joint related procedures during index hospital-
ization. PHC4 includes demographic data from all patient discharges from
170 non-governmental (i.e. non-Veterans Administration) acute care
hospitals in the State of Pennsylvania. We used ICD-9 codes to identify
major complications such as venous thromboembolism (VTE), myocardial
infarction (MI), prosthetic device malfunction, surgical wound infection
and revision knee arthroplasty (ICD-9 codes, 81.55, 0080, 0081, 0082,
0083, and 0084). We examined the associations between gender and all-
cause mortality, major surgical complications. risk of surgical revision at
1-year and at 5-years after index arthroplasty. We adjusted for age, race
or ethnicity, hospital teaching status (teaching or non-teaching), insur-
ance status (none or unknown, Medicaid, Medicare/ government, or
private), hospital procedure volume (0-100 and >100), and length of
hospital stay and the 3M[[Unsupported Character - ]] All Patient
Reﬁned-Diagnosis Related Group Risk of Mortality (APR-ROM) score,
a validated surgical risk score.
Results: In sample consisting of 19,312 primary total knee arthroplasties,
there were 47 deaths (0.2%) at 30 days and 232 (1.2%) at one year. Within
30 days of index TKA, 1076 (5.8%) had major complications. Table 1
shows unadjusted rates of major complications. Compared to women,
men had higher adjusted odds of one-year mortality (Odds Ratio (OR),
1.50; 95% CI, [1.22-1.86]), wound infections (1.23 [1.01-1.49]) and 30-day
readmission (1.44 [0.80-2.57]) after primary TKA. Men also had signiﬁ-
cantly higher risk of revision arthroplasty of the primary TKA at 1-year
(Hazard Ratio(HR), 1.60; 95% CI¼ 1.27-2.03) and 5-years (1.21; 95% CI¼
1.08-1.37). There were no statistically signiﬁcant gender differences in
the rates of short-term complications (i.e., venous thromboembolism,Table 1
Unadjusted rates (n (%)) of surgical outcomes of TKA comparing women to men
Total (n¼19,312)
30-day Complications
Overall complications 1076 (5.57%)
Myocardial Infarction (MI) 92 (0.47%)
Venous thromboembolism (VTE) 510 (2.64%)
Wound infection 461 (2.38%)
Prosthesis failure or device 60 (0.31%)
Readmission and Mortality
30-day readmission 1121 (5.80%)
30 days mortality 47 (0.24%)
1 year mortality 232 (1.20%)
Revision Rates
1-year revision 298 (1.56 %)
5-year revision 1012 (5.76%)myocardial infarction, prosthetic device malfunction or 30-day
mortality).
Conclusion: In a large regional sample of patients who underwent
primary total knee arthroplasty, men had higher rates of adverse surgical
outcomes including higher short- and intermediate-term revision rates
compared to women.
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EFFECTIVENESS OF HYALURONIC ACID INTRA-ARTICULAR INJECTION
FOR PATIENTS WITH KNEE OSTEOARTHRITIS
Y. Kusayama, Y. Akamatsu, K. Kumagai, Y. Fujiwara, T. Saitou. Yokohama
City Univ., Sch. of Med., Kanagawa prefecture Yokohama city, Japan
Purpose: Hyaluronic acid (HA) intra-articular injection for the treatment
of patients with knee osteoarthritis (OA) was ﬁrstly manufactured in 1987,
and has been routinely used in Japan. However, there was only a small
amount of evidence. We have performed ﬁve weekly HA injections
according to the insurance policy. The purpose of this study was to
investigate the change of the nature of synovial ﬂuid (SF) and clinical
symptoms before and after ﬁve weekly HA injections.
Method: Fifteen patients (17 knees) with symptomatic knee OA were
enrolled between January 2010 and July 2011. We conducted 5 weekly
intra-articular injections (Artz, Seikagaku Corporation, Tokyo, Japan) after
drainage of SF in every cases. The arthrocentesis was performed through
lateral mid patellar portal using a 21-gauge needle and syringe, while
avoiding the contamination of blood. We checked total volume of SF
drainage before each HA injection. Also, we measured molecular weight of
hyaluronic acid (HA),chondroitin 4-sulfate (C4S), chondroitin 6-sulfate
(C6S) and keratan sulfate (KS) before ﬁrst and ﬁfth time. We excluded the
case if the SF could not be extracted. We decided not to administer aspirin
and nonsteroidal anti-inﬂammatory drugs six weeks before injections and
during injections. The range of motions (ROM) were measured and clinical
symptoms were using American Knee Society (AKS) knee and function
scores. All knees were classiﬁed using the Kellgren-Lawrence grades (KL
grade), and the femorotibial angle (FTA) was measured on the radiogram.
Result: Four dry knees were excluded before the ﬁrst injection. Thirteen
knees (right 8 and left 5 knees) were examined. Mean age was 63  10.7
years old, andmean bodymass index was 22.12.5 kg/m2. KL grades were
grade 2 in 9 knees and grades 3-4 in 4 knees. Mean FTA was 178.5  3.5.
We didn't have complications and side effects. Mean volume of SF, which
was 11.8ml before ﬁrst injection, and 6.2 m before ﬁfth injection, signiﬁ-
cantly decreased after HA injections (p < 0.05). Mean AKS knee score,
which was 61 points before ﬁrst injection and 77 points before ﬁfth
injection, signiﬁcantly improved after HA injections (p < 0.0001). Mean
ROM, which was 134 10 before ﬁrst injection and 140.8 7 before ﬁfth
injection, signiﬁcantly improved after HA injections (p < 0.009). Mean
molecular weight of HA, C4S, C6S and KS, which were 1.4 mg/ml, 15.1
nmol/m 50.7 nmol/ml and 4.3 micro g/ml, respectively, before ﬁrst injec-
tion, changed to 1.7 mg/ml,12.7 nmol/ml, 41.9 nmol/ml and 3.7 micro g/ml,
respectively, before ﬁfth injection.Female (n¼12,557) Male (n¼6,755) P-value
663 (5.27%) 413 (6.11%) 0.016
52 (0.41%) 40 (0.59%) 0.087
323 (2.57%) 187 (2.76%) 0.418
277 (2.20%) 184 (2.72%) 0.025
36 (0.28%) 24 (0.35%) 0.414
674 (5.36%) 447 (6.61%) 0.0004
25 (0.19%) 22 (0.32%) 0.089
125 (0.99%) 22 (1.58%) 0.0003
162 (1.30%) 136 (2.04%) 0.0001
627 (5.42 %) 385 (6.42%) 0.007
